We are thrilled to announce that VIVEbiotech has been named a finalist in the CMO/CDMO of the Year category at the Advanced Therapies Awards. This recognition, part of the highly regarded Advanced Therapies Week organized by Phacilitate, will take place next week in Dallas, Texas.

Our dedicated team—Jon Albedi, CEO, Natalia Elizalde, Chief Business Development Officer, and Aimi Arrúe, Technical Proposals Technician—, will proudly represent VIVEbiotech at this exciting event. The winners will be announced during a five-star celebration on Wednesday, January 22, at the Union Station Wolfgang Puck in Dallas.

This achievement underscores our commitment to excellence in advanced therapies and serves as a testament to the hard work, innovation, and passion of our entire team. We are deeply honored to be recognized among the best in the industry. This nomination is already an unparalleled recognition, and we are all truly enthusiastic about it.